Arca
Skip to content
Tools
Tools

Rett syndrome

Drug research and approvals for rett syndrome: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 21, 2026, 14 studies of rett syndrome are recruiting on ClinicalTrials.gov, Health Canada has authorized 7 drug trials for it since 2013, FDA has 2 approved and 17 open orphan designations naming it, and the EU has 1 authorised medicine for it.

  • Recruiting worldwide: 14
  • Trials authorized in Canada: 7
  • FDA orphan approvals: 2
  • EU medicines: 1

Recruiting now

Newest posted first, of 14 recruiting on ClinicalTrials.gov ↗

Drug pipeline

Each drug at the furthest stage it has reached for this condition, from ChEMBL's drug indications

Approved 1

Phase 3 5

Phase 2 9

Phase 1 or earlier 2

  • FingolimodSphingosine 1-phosphate receptor agonist
  • EsketamineGlutamate [NMDA] receptor negative allosteric modulator

How its trials ended

87 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrong

Of the 14 whose ending is known, 29% met their primary endpoint, 14% missed it and 57% stopped early.

  • Completed, result not reported4046%
  • Ongoing2124%
  • Status unknown1214%
  • Met its primary endpoint45%
  • Stopped: other or unclear33%
  • Missed its primary endpoint22%
  • Stopped: lack of efficacy22%
  • Stopped: sponsor or business decision22%
  • Stopped: funding11%

Trials authorized in Canada

Newest first; search them all in Canada trials
Jan 30, 2026A phase 3 randomized, double-blind, placebo-controlled, parallel group, multicenter study with open-label extension to evaluate the efficacy and safety of…Fenfluramine (ZX008)UCBPending
Jun 21, 2024Reveal pediatric study: an open-label, randomized, dose-escalation and dose-expansion study of the safety tolerability and efficacy of a single it…TSHA-102 / Prednisolone / Sirolimus / MethylprednisoloneTaysha Gene TherapiesOngoing
Mar 25, 2022An open-label, randomized, dose-escalation and dose-expansion study of the safety and preliminary efficacy of a single intrathecal administration of TSHA-102,…TSHA-102 / PrednisoloneTaysha Gene TherapiesOngoing
May 5, 2021A 40-week, open-label extension study of trofinetide for the treatment of girls and women with rett syndromeTrofinetideACADIA PharmaceuticalsPending
Apr 7, 2021A double-blind, randomized, placebo-controlled, safety and efficacy study of ANAVEX2-73 in patients with rett syndromeBlarcamesineAnavex Canada Ltd.Closed
Nov 12, 2020A randomized, double-blind,placebo-controlled, parallel-group study of trofinetide for the treatment of girls and women with rett syndromeTrofinetideACADIA PharmaceuticalsPending
Mar 25, 2020A randomized, double-blind, placebo-controlled trial to investigate the efficacy and safety of cannabidiol oral solution (GWP42003-p; cbd-os) in patients with…Cannabis (cannabidiol;GWP42003-P)GW Research LimitedPending

FDA orphan designations

Approved first, then open designations, newest first; 15 of 19
Dec 11, 2025Daybue StixTreatment of Rett syndrome in adults and pediatric patients 2 years of age and olderACADIA Pharmaceuticals Inc.Approved
Mar 10, 2023DaybueTreatment of Rett syndrome in adults and pediatric patients 2 years of age and olderACADIA Pharmaceuticals Inc.Approved
Sep 6, 2026Recombinant serotype 9 adeno-associated virus encoding a…Treatment of Rett syndromeGeneTrek Therapeutics (Shanghai) Co., Ltd.Designated
Jul 26, 2026(S)-1-(L-Leucyl-L-arginyl)-2-methylpyrrolidine-2-carboxamideTreatment of Rett syndromeENCUE, Inc.Designated
Nov 25, 2024CBDA dominant extract of Cannabis sativa / Low (<0.3% w/w)…Treatment of Rett syndromeNeurotech International LimitedDesignated
May 24, 2024VorinostatTreatment of Rett syndromeUnravel Biosciences, Inc.Designated
Mar 11, 2024Self-complementary Adeno-Associated Virus 9 containing…Treatment of Rett syndromeGenecombio Ltd.Designated
Mar 29, 20231-O-octadecyl-2-arachidonoyl-sn-glycerol-3-phosphoethanolami…Treatment of Rett syndromeNeurocores Inc.Designated
Feb 27, 2023Recombinant serotype 9 adeno-associated virus (AAV)…Treatment of Rett syndromeNeurogene Inc.Designated
Feb 1, 2023KetamineTreatment of Rett SyndromePharmaTher Inc.Designated
Apr 19, 2022Methyl…Treatment of Rett SyndromeDepYmed, Inc.Designated
Oct 7, 2020Recombinant serotype 9 adeno-associated virus encoding a…Treatment for Rett syndromeTaysha Gene TherapiesDesignated
Jun 22, 2017[(S)-1-(L-valyl)-N_((S)-1-phenyl-2-(pyridin-2-yl)ethyl)pyrro…Treatment of Rett SyndromeBiohaven Pharmaceutical Holding Company, Ltd.Designated
Nov 30, 2016CannabidivarinTreatment of Rett syndromeJazz Pharmaceuticals Research UK LimitedDesignated
Nov 3, 20166'-(R)-Methyl-5-O-(5-amino-5,6-dideoxy-a-L-talofuranosyl)-…Treatment of Rett syndromeEloxx Pharmaceuticals, Ltd.Designated

Medicines authorised in the EU

Newest first
AuthorisedMedicineHolderEPAR
Aug 20, 2026DaybuTrofinetide · orphanAcadia Pharmaceuticals B.V.EMA ↗

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.